Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0GZ5F
|
||||
Former ID |
DIB009288
|
||||
Drug Name |
CX-1001
|
||||
Synonyms |
SERT ligand (cancer), Celentyx; Reprofiled marketed drug (B-cell cancers), Celentyx
|
||||
Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Investigative | [543976] | ||
Company |
Celentyx Ltd
|
||||
Target and Pathway | |||||
Target(s) | Sodium-dependent serotonin transporter | Target Info | Binder | [543976] | |
KEGG Pathway | Serotonergic synapse | ||||
NetPath Pathway | TCR Signaling Pathway | ||||
References |
If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.